These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

323 related items for PubMed ID: 25769925

  • 1. Cutting edge: identification of autoreactive CD4+ and CD8+ T cell subsets resistant to PD-1 pathway blockade.
    Pauken KE, Nelson CE, Martinov T, Spanier JA, Heffernan JR, Sahli NL, Quarnstrom CF, Osum KC, Schenkel JM, Jenkins MK, Blazar BR, Vezys V, Fife BT.
    J Immunol; 2015 Apr 15; 194(8):3551-3555. PubMed ID: 25769925
    [Abstract] [Full Text] [Related]

  • 2. CD8+ T cells undergo activation and programmed death-1 repression in the liver of aged Ae2a,b-/- mice favoring autoimmune cholangitis.
    Concepcion AR, Salas JT, Sáez E, Sarvide S, Ferrer A, Portu A, Uriarte I, Hervás-Stubbs S, Oude Elferink RP, Prieto J, Medina JF.
    Oncotarget; 2015 Oct 06; 6(30):28588-606. PubMed ID: 26396175
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. TGFβ-dependent expression of PD-1 and PD-L1 controls CD8(+) T cell anergy in transplant tolerance.
    Baas M, Besançon A, Goncalves T, Valette F, Yagita H, Sawitzki B, Volk HD, Waeckel-Enée E, Rocha B, Chatenoud L, You S.
    Elife; 2016 Jan 29; 5():e08133. PubMed ID: 26824266
    [Abstract] [Full Text] [Related]

  • 5. Differential control of CD4(+) T-cell subsets by the PD-1/PD-L1 axis in a mouse model of allergic asthma.
    McAlees JW, Lajoie S, Dienger K, Sproles AA, Richgels PK, Yang Y, Khodoun M, Azuma M, Yagita H, Fulkerson PC, Wills-Karp M, Lewkowich IP.
    Eur J Immunol; 2015 Apr 29; 45(4):1019-29. PubMed ID: 25630305
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. PD-L1-deficient mice show that PD-L1 on T cells, antigen-presenting cells, and host tissues negatively regulates T cells.
    Latchman YE, Liang SC, Wu Y, Chernova T, Sobel RA, Klemm M, Kuchroo VK, Freeman GJ, Sharpe AH.
    Proc Natl Acad Sci U S A; 2004 Jul 20; 101(29):10691-6. PubMed ID: 15249675
    [Abstract] [Full Text] [Related]

  • 9. Reactive glia promote development of CD103+ CD69+ CD8+ T-cells through programmed cell death-ligand 1 (PD-L1).
    Prasad S, Hu S, Sheng WS, Chauhan P, Lokensgard JR.
    Immun Inflamm Dis; 2018 Jun 20; 6(2):332-344. PubMed ID: 29602245
    [Abstract] [Full Text] [Related]

  • 10. B7H1/CD80 interaction augments PD-1-dependent T cell apoptosis and ameliorates graft-versus-host disease.
    Deng R, Cassady K, Li X, Yao S, Zhang M, Racine J, Lin J, Chen L, Zeng D.
    J Immunol; 2015 Jan 15; 194(2):560-74. PubMed ID: 25488990
    [Abstract] [Full Text] [Related]

  • 11. Reduced tumor-antigen density leads to PD-1/PD-L1-mediated impairment of partially exhausted CD8⁺ T cells.
    Kaiser AD, Schuster K, Gadiot J, Borkner L, Daebritz H, Schmitt C, Andreesen R, Blank C.
    Eur J Immunol; 2012 Mar 15; 42(3):662-71. PubMed ID: 22144176
    [Abstract] [Full Text] [Related]

  • 12. PD-1/PD-L1 expression on CD(4+) T cells and myeloid DCs correlates with the immune pathogenesis of atrial fibrillation.
    Liu L, Zheng Q, Lee J, Ma Z, Zhu Q, Wang Z.
    J Cell Mol Med; 2015 Jun 15; 19(6):1223-33. PubMed ID: 25810125
    [Abstract] [Full Text] [Related]

  • 13. CD4 T Cell Depletion Substantially Augments the Rescue Potential of PD-L1 Blockade for Deeply Exhausted CD8 T Cells.
    Penaloza-MacMaster P, Provine NM, Blass E, Barouch DH.
    J Immunol; 2015 Aug 01; 195(3):1054-63. PubMed ID: 26116499
    [Abstract] [Full Text] [Related]

  • 14. Intestinal tolerance is converted to autoimmune enteritis upon PD-1 ligand blockade.
    Reynoso ED, Elpek KG, Francisco L, Bronson R, Bellemare-Pelletier A, Sharpe AH, Freeman GJ, Turley SJ.
    J Immunol; 2009 Feb 15; 182(4):2102-12. PubMed ID: 19201863
    [Abstract] [Full Text] [Related]

  • 15. Programmed cell death 1 (PD-1) regulates the effector function of CD8 T cells via PD-L1 expressed on target keratinocytes.
    Okiyama N, Katz SI.
    J Autoimmun; 2014 Sep 15; 53():1-9. PubMed ID: 25047812
    [Abstract] [Full Text] [Related]

  • 16. Cutting Edge: Programmed death (PD) ligand-1/PD-1 interaction is required for CD8+ T cell tolerance to tissue antigens.
    Martin-Orozco N, Wang YH, Yagita H, Dong C.
    J Immunol; 2006 Dec 15; 177(12):8291-5. PubMed ID: 17142723
    [Abstract] [Full Text] [Related]

  • 17. PD-1 upregulated on regulatory T cells during chronic virus infection enhances the suppression of CD8+ T cell immune response via the interaction with PD-L1 expressed on CD8+ T cells.
    Park HJ, Park JS, Jeong YH, Son J, Ban YH, Lee BH, Chen L, Chang J, Chung DH, Choi I, Ha SJ.
    J Immunol; 2015 Jun 15; 194(12):5801-11. PubMed ID: 25934860
    [Abstract] [Full Text] [Related]

  • 18. Blockade of PD-1/PD-L1 promotes adoptive T-cell immunotherapy in a tolerogenic environment.
    Blake SJ, Ching AL, Kenna TJ, Galea R, Large J, Yagita H, Steptoe RJ.
    PLoS One; 2015 Jun 15; 10(3):e0119483. PubMed ID: 25741704
    [Abstract] [Full Text] [Related]

  • 19. Dual control of antitumor CD8 T cells through the programmed death-1/programmed death-ligand 1 pathway and immunosuppressive CD4 T cells: regulation and counterregulation.
    Currie AJ, Prosser A, McDonnell A, Cleaver AL, Robinson BW, Freeman GJ, van der Most RG.
    J Immunol; 2009 Dec 15; 183(12):7898-908. PubMed ID: 20007574
    [Abstract] [Full Text] [Related]

  • 20. PD-1 pathway-mediated regulation of islet-specific CD4+ T cell subsets in autoimmune diabetes.
    Martinov T, Spanier JA, Pauken KE, Fife BT.
    Immunoendocrinology (Houst); 2016 Dec 15; 3():. PubMed ID: 27656680
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.